Loading...

FDA Approval And Expanding Network Will Grow US Sleep Market

Published
06 Apr 25
Updated
01 May 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-48.6%
7D
-2.0%

Author's Valuation

€12.366.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 01 May 25

Fair value Increased 0.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 24 Apr 25

AnalystConsensusTarget has decreased profit margin from 3.1% to 2.6% and increased future PE multiple from 193.7x to 228.2x.

Shared on 17 Apr 25

Fair value Decreased 28%

AnalystConsensusTarget has decreased future PE multiple from 259.7x to 193.7x.

Shared on 09 Apr 25

Fair value Increased 19%

AnalystConsensusTarget has increased future PE multiple from 207.7x to 259.7x.